Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × giredestrant × Clear all

Phase

Status

Sponsor Class

INDUSTRY 9 OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 34 Docetaxel 26 Tamoxifen 23 Paclitaxel 22 Doxorubicin 21 Trastuzumab 19 Radiotherapy 16 Epirubicin 13 Letrozole 10 Fluorouracil 9 Capecitabine 8 Bevacizumab 8 Anastrozole 8 exemestane 7 Immunohistochemistry 7 Gene Expression Profiling 7 Filgrastim 7 Methotrexate 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 palbociclib 5 Zoledronic Acid 5 Microarray Analysis 5 Absorptiometry, Photon 5 Vinorelbine 4 Surgical Procedures, Operative 4 Reverse Transcriptase Polymerase Chain Reaction 4 Psychiatric Rehabilitation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05896566 2026-02-24

PREcoopERA

ETOP IBCSG Partners Foundation

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡